Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Jan;30(1):216–218. doi: 10.1128/jcm.30.1.216-218.1992

Detection of human immunodeficiency virus type 1 antibody by using commercially available whole-cell viral lysate, synthetic peptide, and recombinant protein enzyme immunoassay systems.

J E Johnson 1
PMCID: PMC265024  PMID: 1734055

Abstract

A total of 575 serum specimens received for human immunodeficiency virus type 1 (HIV-1) antibody determination were tested prospectively by enzyme immunoassay with a whole-cell viral lysate (VL) (Genetic Systems Corp.), a synthetic peptide (SP) (United Biomedical, Inc.), and a recombinant protein (RCP) (Syva Co.). Concordance of all three antigens was noted for 559 of 575 (97.2%) specimens tested. Of the specimens tested, 90 (15.7%) were positive and 469 (84.3%) were negative. Retrospective testing by SP and RCP of 86 specimens indeterminate for HIV-1 antibody by VL, Western blot (immunoblot), and immunofluorescence was also performed. The results of both phases of this study indicate that the specificity of the three antigens is RCP greater than SP greater than VL. As noted from the prospective phase, the sensitivities of the antigens appear to be equivalent, indicating that the RCP and SP systems could be used in place of, or to confirm, a VL enzyme immunoassay screening test.

Full text

PDF
216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burke D. S., Brandt B. L., Redfield R. R., Lee T. H., Thorn R. M., Beltz G. A., Hung C. H. Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide. Comparison to Western blot on 2707 consecutive serum samples. Ann Intern Med. 1987 May;106(5):671–676. doi: 10.7326/0003-4819-106-5-671. [DOI] [PubMed] [Google Scholar]
  2. Bäcker U., Gathof A., Howe J., Strobel E., Deinhardt F., Gürtler L., Grob P., Joller-Jemelka H., Kühnl P., Seidl S. A new second-generation anti-HIV-1 enzyme immunoassay using recombinant envelope and core proteins. AIDS. 1988 Dec;2(6):477–480. doi: 10.1097/00002030-198812000-00011. [DOI] [PubMed] [Google Scholar]
  3. Cumming S. A., McPhee D. A., Maskill W. J., Kemp B. E., Doherty R. R., Gust I. D. Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies. AIDS. 1990 Jan;4(1):83–86. doi: 10.1097/00002030-199001000-00012. [DOI] [PubMed] [Google Scholar]
  4. Gnann J. W., Jr, Schwimmbeck P. L., Nelson J. A., Truax A. B., Oldstone M. B. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis. 1987 Aug;156(2):261–267. doi: 10.1093/infdis/156.2.261. [DOI] [PubMed] [Google Scholar]
  5. Landesman S. H., Ginzburg H. M., Weiss S. H. The AIDS epidemic. N Engl J Med. 1985 Feb 21;312(8):521–525. doi: 10.1056/nejm198502213120829. [DOI] [PubMed] [Google Scholar]
  6. Lepine D. G., Neumann P. W., Frenette S. L., O'Shaughnessy M. V. Evaluation of a human immunodeficiency virus test algorithm utilizing a recombinant protein enzyme immunoassay. J Clin Microbiol. 1990 Jun;28(6):1169–1171. doi: 10.1128/jcm.28.6.1169-1171.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Närvänen A., Korkolainen M., Suni J., Korpela J., Kontio S., Partanen P., Vaheri A., Huhtala M. L. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection. J Med Virol. 1988 Oct;26(2):111–118. doi: 10.1002/jmv.1890260202. [DOI] [PubMed] [Google Scholar]
  8. Ozanne G., Fauvel M. Performance and reliability of five commercial enzyme-linked immunosorbent assay kits in screening for anti-human immunodeficiency virus antibody in high-risk subjects. J Clin Microbiol. 1988 Aug;26(8):1496–1500. doi: 10.1128/jcm.26.8.1496-1500.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Parry J. V., McAlpine L., Avillez M. F. Sensitivity of six commercial enzyme immunoassay kits that detect both anti-HIV-1 and anti-HIV-2. AIDS. 1990 Apr;4(4):355–360. doi: 10.1097/00002030-199004000-00012. [DOI] [PubMed] [Google Scholar]
  10. Schulz T. F., Aschauer J. M., Hengster P., Larcher C., Wachter H., Fleckenstein B., Dierich M. P. Envelope gene-derived recombinant peptide in the serodiagnosis of human immunodeficiency virus infection. Lancet. 1986 Jul 12;2(8498):111–112. doi: 10.1016/s0140-6736(86)91648-x. [DOI] [PubMed] [Google Scholar]
  11. Smith R. S., Naso R. B., Rosen J., Whalley A., Hom Y. L., Hoey K., Kennedy C. J., McCutchan J. A., Spector S. A., Richman D. D. Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection. J Clin Microbiol. 1987 Aug;25(8):1498–1504. doi: 10.1128/jcm.25.8.1498-1504.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Thorn R. M., Beltz G. A., Hung C. H., Fallis B. F., Winkle S., Cheng K. L., Marciani D. J. Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody. J Clin Microbiol. 1987 Jul;25(7):1207–1212. doi: 10.1128/jcm.25.7.1207-1212.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wang J. J., Steel S., Wisniewolski R., Wang C. Y. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc Natl Acad Sci U S A. 1986 Aug;83(16):6159–6163. doi: 10.1073/pnas.83.16.6159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Weiss S. H., Goedert J. J., Sarngadharan M. G., Bodner A. J., Gallo R. C., Blattner W. A. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA. 1985 Jan 11;253(2):221–225. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES